Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Elutia Inc ELUT

Healthcare Biotechnology
Elutia Inc. is a commercial-stage company, which has developed a portfolio of products using both human and porcine tissue. Its portfolio of products spans the Device Protection, Women’s Health and Cardiovascular markets. These products are primarily sold to healthcare providers or commercial partners. In Device Protection, it sells CanGaroo, a biological envelope, that is indicated for use... see more

Recent & Breaking News (NDAQ:ELUT)

Aziyo Biologics to Participate in the 2021 Cantor Global Healthcare Conference

GlobeNewswire September 15, 2021

Aziyo Biologics Appoints Peter G. Edwards as General Counsel

GlobeNewswire August 31, 2021

Aziyo Biologics Reports Second Quarter 2021 Financial Results

GlobeNewswire August 9, 2021

Aziyo Biologics to Report Second Quarter 2021 Financial Results on Monday, August 9, 2021

GlobeNewswire July 26, 2021

Aziyo Biologics Comments on June 2nd Voluntary Recall of One Lot of its FiberCel Fiber Viable Bone Matrix

GlobeNewswire June 7, 2021

Aziyo Biologics Reports First Quarter 2021 Financial Results and Increases 2021 Revenue Guidance

GlobeNewswire May 4, 2021

Aziyo Biologics Announces Initiation of De Novo CanGaroo Clinical Study

GlobeNewswire April 28, 2021

Aziyo Biologics to Participate in the Truist Securities Life Sciences Summit

GlobeNewswire April 26, 2021

Aziyo Biologics to Report First Quarter 2021 Financial Results on Tuesday, May 4, 2021

GlobeNewswire April 20, 2021

Aziyo Biologics Reports Fourth Quarter and Full Year 2020 Financial Results

GlobeNewswire March 1, 2021

Aziyo Biologics to Participate in the Cowen 41st Annual Health Care Conference

GlobeNewswire February 18, 2021

Aziyo Biologics Announces First Patient Enrolled in HEAL Study

GlobeNewswire February 17, 2021

Aziyo Biologics to Report Fourth Quarter and Full Year 2020 Financial Results on Monday, March 1, 2021

GlobeNewswire February 15, 2021

Aziyo Biologics Announces Product Design Completion for its Next Generation CanGaroo® Envelope for Implantable Electronic Devices

GlobeNewswire February 11, 2021

Aziyo Biologics Announces Updated CanGaroo® Envelope Label in European Markets to Allow for Hydration in an Antibiotic Solution

GlobeNewswire January 28, 2021

Surgalign Holdings Announce the Commercial Launch of ViBone® Moldable and the First Clinical Implantation

GlobeNewswire January 12, 2021

Aziyo Biologics Reports Third Quarter 2020 Financial Results

GlobeNewswire November 19, 2020

Surgalign Holdings and Aziyo Biologics Announce Expanded Distribution Agreement

GlobeNewswire November 16, 2020

Aziyo Biologics Awarded Breakthrough Technology Contract with Premier Inc.

GlobeNewswire November 12, 2020

Aziyo Biologics to Report Third Quarter 2020 Financial Results on Thursday, November 19, 2020

GlobeNewswire November 5, 2020